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Abstract
  
	 Caffeic	 acid,	 a	 natural	 substance	 found	majorly	 in	 fruits,	 grains,	 and	 herbs,	 is	
known	 to	 have	 therapeutic	 benefits.	 One	 of	 which	 is	 to	 inhibit	 bone	 resorption	 by	
targeting	 osteoclastogenesis	 through	 inhibition	 of	 the	 Cathepsin	 K,	 p38	 Mitogen-
activated	Protein	Kinase	 (MAPK),	Nuclear	Factor	of	Activated	T-cells	 c1	 (NFATc1)	and	
Nuclear	Factor	kB	(NFkB).	Besides	p38	MAPK,	the	c-Jun	N-terminal	kinase	(JNK)/stress-
activated	protein	kinases	(SAPK),	another	member	of	MAPK	family,	has	been	reported	
to	play	important	roles	in	osteoclastogenesis.	Hence,	current	study	was	undertaken	in	
order	 to	 investigate	mechanism	of	 Caffeic	Acid	 towards	 JNK/SAPK	pathway.	Tartrate	
Resistant	Acid	Phosphatase	(TRAP)	staining	was	performed	on	caffeic	acid-treated	and	
RANKL-TNFα-induced	RAW-D	cells.	Western	blot	analysis	was	performed	to	detect	JNK/
SAPK	 and	 phosphorylated-JNK/SAPK.	 Protein	 bands	 were	 quantified	 and	 statistically	
analyzed.	 Treatment	 of	 10	 μg/mL	 Caffeic	Acid	 inhibited	 20	 ng/mL	 RANKL	 and	 1	 ng/
mL	 TNFα-induced	 RAW-D	 differentiation	 into	 TRAP+	 osteoclast-like	 polynuclear	 cells.	
Induction	of	20	ng/mL	of	RANKL	and	1	ng/mL	of	TNFa	 for	0.2	or	1	hour,	significantly	
increase	phosphorylation	of	JNK/SAPK	as	compared	with	control.	Treatment	of	10	µg/mL	
Caffeic	Acid	significantly	inhibited	the	20	ng/mL	of	RANKL	and	1	ng/mL	of	TNFa-induced	
phosphorylation	of	JNK/SAPK.	Taken	together,	Caffeic	Acid	could	inhibit	the	RANKL	and	
TNFa-induced	osteoclastogenesis	through	JNK/SAPK.
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INTRODUCTION
 Receptor Activator of Nuclear Factor κB 
Ligand (RANKL) and Tumor Necrosis Factor (TNF)
a have been shown to induce osteoclastogenesis 
effectively in RAW-D cells (Kukita, et al., 2004). 
Several second messengers and transcription factors 
of osteoclastogenic pathway induced by RANKL 
and TNFa in RAW-D cells have been reported, 
including TNF Receptor Associated Factor 6 
(TRAF6) (Sandra, et al., 2013) and Nuclear Factor 
of Activated T-cells c1 (NFATc1) (Kukita, et al., 
2004). These messengers and factors were shown to 
be important in osteoclastogenesis, hence inhibition 
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of each factor could decrease number of osteoclast-
like cells. 
 Inhibition of osteoclastogenesis has 
been investigated due to the potential of 
osteoclastogenesis in bone resorption. In dentistry, 
bone resorption could be occured in periodontitis 
(Bartold, et al., 2010)  and ameloblastoma 
(Sandra, et al., 2005). In dental implant treatment, 
osteoclastogenesis should also be controlled and 
minimized so that the implant could be intact and 
functionally supported in articular bone (Shannon, 
et al., 2011). Osteoprotegerin (OPG) as an agent 
to provide the osteoclastogenic inhibition, also 
binds with tumor necrosis factor-related apoptosis-
inducing ligand (TRAIL). Therefore, OPG also 
provides an inhbition of TRAIL-induced apoptosis 
in ameloblastomas (Sandra, et al., 2006). The 
concept of OPG was then used for the development 
of a new agent, denosumab (Hamdy, 2008). Other 
alternatives have been investigated as well, such as 
materials derived from natural resources, including 
herbs (Ming, 2013).
 Caffeic Acid, one of the most common phenolic 
acids frequently found in fruits, grains, and herbs, 
has been widely studied because of it’s ability to 
protect human cells from several diseases, such as 
cancer (Sandra and Sidharta, 2017),  Alzheimer 
(Habtemariam, 2017) and bone resorption (Sandra, 
et al., 2011, Sandra, et al., 2013). Caffeic Acid 
fights osteosarcoma cells by inducing Caspases, 
including Caspase-8, -9, and -3, leading them into 
apoptosis (Sandra, et al., 2017). Caffeic Acid has 
also been reported to inhibit bone resorption by 
targeting osteoclastogenesis through inhibition of 
the Cathepsin K, NFATc1 (Tang, et al., 2006) and 
Nuclear Factor kB (NFkB) (Sandra, et al., 2011). 
Recently we reported that Caffeic Acid inhibits 
RANKL and TNFa-induced p38 Mitogen-activated 
Protein Kinase (MAPK) osteoclastogenic pathway 
in RAW-D cells (Sandra and Ketherin, 2018). 
Besides p38 MAPK, the c-Jun N-terminal kinase 
(JNK), also referred as stress-activated protein 
kinases (SAPK), is another member of MAPK 
family that has been reported to play important 
roles in many different intracellular signaling 
pathways and control several functions including 
cell proliferation, differentiation, transformation, 
apoptosis, migration, and cytoskeletal integrity 
(Nishina, et al., 2004). Hence, this study was 
undertaken in order to investigate mechanism of 
Caffeic Acid towards JNK/SAPK pathway.
MATERIALS AND METHODS
Cell Culture
 RAW-D cells were cultured in α-MEM 
(GIBCO-BRL, Grand Island, NY, USA) with 10% 
FBS (Biosource, Camarillo, CA, USA) at 37°C in a 
humidified incubator with 5% CO2. 
in vitro Osteoclastogenesis
 Six thousand RAW-D cells were treated with 
10 µg/mL Caffeic Acid (Wako, Osaka, Japan), 2 
hours prior to the osteoclastogenic induction of 
20 ng/mL RANKL (PeproTech, London, UK) and 
1 ng/mL TNFa (Roche Molecular Biochemicals, 
Mannheim, Germany). After 3 days, Tartrate 
Resistant Acid Phosphatase (TRAP) staining was 
performed using Leukocyte Acid Phosphatase Kit 
(Sigma-Aldrich, St. Louis, MO, USA). TRAP+ 
polynuclear cells (PNCs) were documented under 
an inverted microscope.
Western Blot
 Cells were lysed using buffer containing 
10 mM Tris buffer (pH 7.4), 150 mM NaCl, 
1% Triton-X100 and protease inhibitor cocktail 
(Sigma-Aldrich). Protein was separated using 
sodium dodecyl sulfate (SDS)-polyacrylamide gel 
electrophoresis and transferred to a nitrocellulose 
membrane (Bio-Rad, Hercules, CA, USA). After 
transferring to membrane, the membrane was 
blocked with 5% skim milk in phosphate buffer 
saline (PBS) (pH 7.4). Then the membrane was 
probed with 1:1000 diluted rabbit polyclonal anti-
phospho-JNK/SAPK MAPK (Thr183/Tyr185) 
antibody (Cell Signaling Technology, Danvers, 
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MA, USA). The secondary antibody was 1:2000 
diluted horseradish peroxidase-conjugated donkey 
anti-rabbit antibody (Cell Signaling Technology). 
The bound antibodies were visualized using Immun 
Star HRP Chemiluminescent Kit (Bio-Rad). 
Membrane was then stripped with Seppro stripping 
buffer (Sigma-Aldrich), blocked with 5% skim milk 
in PBS, probed with rabbit polyclonal anti-SAPK/
JNK (Cell Signaling Technology), bound with 
same secondary antibody and visualized with the 
chemiluminescent kit. All visualized bands were 
captured using Alliance 4.7 (UVItech, Cambridge, 
UK) and quantified using UVIband software 
(UVItech, Cambridge, UK). 
Statistical Analysis
 Analyses were performed using IBM SPSS for 
Windows version 20.0 (IBM Corp., Armonk, NY, 
USA). T-test was used to determine the statistical 
differences between the means of experiments. 
A probability value <0.05 was considered to be 
statistically significant.  
RESULTS
RANKL and TNFα-induced Osteoclastogenesis 
was Inhibited by Caffeic Acid
 As shown in Figure 1B, 20 ng/mL RANKL and 
1 ng/mL TNFα successfully induced differentiation 
of RAW-D cells into TRAP+ osteoclast-like PNCs. 
Figure 1. RANKL and TNFα-induced osteoclastogenesis was inhibited by caffeic acid in RAW-D cells. A:	Untreated	
RAW-D	cells.	B:	20	ng/mL	RANKL	and	1	ng/mL	TNFa-induced	RAW-D	cells.	C:	RAW-D	cells	were	treated	with	10	
µg/mL	caffeic	acid	followed	by	induction	of	20	ng/mL	RANKL	and	1	ng/mL	TNFa.		Bar:	100	µm.
Treatment of 10 μg/mL Caffeic Acid inhibited 
20 ng/mL RANKL and 1 ng/mL TNFα-induced 
RAW-D differentiation into TRAP+ osteoclast-like 
PNCs (Figure 1C).
Caffeic Acid Inhibited RANKL and TNFα-
induced Phosphorylation of JNK/SAPK in 
RAW-D Cells
 Induction of 20 ng/mL of RANKL and 1 ng/mL 
of TNFa for 0.2 or 1 hour, significantly (p=0,000, 
T test) increase phosphorylation of JNK/SAPK as 
compared with control (Figure 2). Treatment of 10 
µg/mL Caffeic Acid significantly (p=0,000, T test) 
inhibited the 20 ng/mL of RANKL and 1 ng/mL of 
TNFa-induced phosphorylation of JNK/SAPK.
DISCUSSION
 Osteoclast derived from hematopoietic 
monocyte precursors that balance the function 
of skeletal modeling and repair through complex 
pathways. This resorbing cell can be resulted 
under the regulation of critical factors, RANKL 
and OPG (Boyce and Xing, 2008). The  RANK-
RANKL signaling pathway activates a series of 
TRAFs and can lead to the activation of nuclear 
factors and second messengers, such as JNK/SAPK 
(Hyeon, et al., 2013).  Among the nuclear factors, 
activated NFkB will also promote the inflammatory 
osteolysis (Lin, et al., 2017). 
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 Previous study has shown that caffeic acid did 
not significantly affect the expression of TRAF6 
(Sandra, et al., 2013), but significantly inhbited the 
expression of p38 MAPK (Sandra, et al., 2018), as 
well as NFkB (Sandra, et al., 2011) in RANKL and 
TNFα-induced RAW-D cells. Multiple studies have 
associated RANKL-mediated osteoclastogenesis 
with JNK/SAPK. A correlation between the 
osteoclast differentiation and RANKL-induced 
JNK/SAPK activation has been established, 
suggesting that JNK is a strong key that regulates 
osteoclastogenesis (Islam, et al., 2007).  
 In the present study, RANKL and TNFα 
induced formation of TRAP+ PNCs, meanwhile 
treatment of caffeic acid significantly inhibited the 
formation of RANKL and TNFα-induced TRAP+ 
PNCs. The upregulated phosphorylation of JNK/
SAPK was confirmed in RANKL and TNFα-
induced RAW-D cell, meanwhile the treatment 
of caffeic acid clearly showed the significant 
inhibition of phosphorylated JNK/SAPK. These 
results suggests that despite p38 MAPK, caffeic 
acid might have ability to inhibit the risk of bone 
Figure 2. Caffeic acid inhibited 
RANKL and TNFa-induced phos-
phorylation of JNK/ SAPK in 
RAW-D cells. RAW-D	 cells	 were	
treated	with/without	 10	 µg/mL	
caffeic	 acid	 and	 induced	 with/
without	20	ng/mL	of	RANKL	and	
1	ng/mL	of	TNFa	 for	 0,	 0.2,	 1,	
6	and	12	hours.	Cells	were	lysed	
and	 subjected	 to	 immunoblot-
ting	 assay	 using	 anti-JNK/SAPK	
and	 anti-phosphorylated	 JNK/
SAPK	antibodies.	Data	represent	
a	typical	result	from	3	indepen-
dent	experiments.
destruction through JNK/SAPK signaling pathway 
as well. Since other RANKL and TNFa-induced 
osteoclastogenic signaling pathways have been 
reported, inhibition of caffeic acid should also be 
pursued further in those signaling pathways.
CONCLUSION
 Taken together, caffeic acid could inhibit the 
RANKL and TNFa-induced osteoclastogenesis 
through JNK/SAPK.
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